Everything you care about in one place
Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.
Get Feederfiercebiotech.com
FierceBiotech: Biotech
Get the latest updates from FierceBiotech: Biotech directly as they happen.
Follow now 98 followers
Latest posts
Last updated about 2 hours ago
AstraZeneca, after phase 3 miss, posts subgroup data behind pitch for rare disease approval
about 2 hours ago
AstraZeneca has shared data it believes can rescue anselamimab from a phase...
Agios’ next-gen PK drug fails blood cancer study but sickle cell disease ambitions remain undimmed
about 3 hours ago
Agios Pharmaceuticals’ next-gen pyruvate kinase (PK) activator has failed a phase 2...
Boston, China and the future of biotech
about 3 hours ago
Senior Writer Darren Incorvaia talks with industry leaders and experts from Flagship...
Chutes & Ladders—Allogene swaps in CMO as new chief exec
about 4 hours ago
After more than eight years at the helm of off-the-shelf CAR-T company...
ASCO: Lilly debuts ‘strong’ bladder cancer data for potential Padcev challenger
about 4 hours ago
Eli Lilly took to the stage at the American Society of Clinical...
ASCO: BMS’ CELMoD drug doubles PFS in ‘incredibly exciting’ ph. 3 myeloma study
about 4 hours ago
Bristol Myers Squibb may have gone big in its pursuit of cereblon...
Gilead scraps lead arthritis drug from $405M MiroBio buyout in latest blow to BTLA agonist field
about 5 hours ago
Gilead has abandoned work on the lead rheumatoid arthritis drug from its...
Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation
about 8 hours ago
Pfizer is paying Innovent $650 million upfront to partner on cancer drug...
FDA extends Beren’s rare disease review after info request, further stretching saga
1 day ago
The FDA has delayed its approval decision on Beren Therapeutics’ rare disease...
Hoth Therapeutics’ pivot to AI in space sees stock rocket after rebrand
1 day ago
Hoth Therapeutics’ search for salvation in the stars appears to have been...
Novartis ‘always looking’ for further ways to shuttle drugs to brain despite run of recent deals
1 day ago
Novartis may be launching an array of vehicles to shuttle drugs across...
GSK’s hepatitis B drug cures one-fifth of patients in ‘major step’ for pervasive disease
1 day ago
GSK is pulling back the curtain on the phase 3 success of...